Wednesday 12th May 2021
|Text too small?|
A commercial agreement between Rua Bioscience and Medbloom Limited to supply raw biomass has been concluded by mutual understanding. Rua is now focused on progressing existing discussions with alternative grower partners to supplement the company's existing cultivation facility in Ruatorea.
The conclusion of this agreement will not delay Rua's first export revenue.
In October 2020, Medbloom (a subsidiary of Blooming Hill Flowers) signed a commercial agreement to grow and supply Rua with cannabis plant material - with production expected to begin in 2022. The agreement was contingent upon Medbloom securing adequate capital to expand its operation.
Though disappointed, Rua CEO Rob Mitchell says Rua is well-placed to fill the gap.
Rua is in advanced discussions with a number of other grower partners already producing biomass, with strong horticultural experience and the capability to deliver the volumes needed. There is significant scope for partnership opportunity in the evolving New Zealand industry. Rua understands Medsafe has issued 27 commercial licences under the medicinal cannabis scheme. Other growers will provide the geographical diversification originally offered by Medbloom, safeguarding Rua from potential environmental and other external factors that may affect production.
Please see the link below for details
No comments yet
BIF - Acquires shares in Hot Lime Labs
RUA - Cann Group granted TGA GMP for Mildura facility
AFI - Invitation to Results Webcast
PFI Share Buyback Programme to Pause
Greenfern Industries Limited ("GFI") - Late Annual Report
FSF - Monthly Allotment/ Redemption Notice
1st July 2022 Morning Report
General Capital Releases 2022 Annual Report
Fonterra, NZX, EEX confirm GDT strategic partnership
BIF - Annual Report 2022